Literature DB >> 35467259

PPARγ Dysfunction in the Medial Prefrontal Cortex Mediates High-Fat Diet-Induced Depression.

Cong-Cong Fu1, Xin-Yi Zhang1, Liu Xu1, Hui-Xian Huang1, Shuang Xu1, Qiao-Qi Wu1, Zhen Wang1, Xi Gu1, Li-Fang Lin1, Song Lin1, Ying-Ying Fang1, Xiong Cao1, Xuemin Wang2.   

Abstract

Epidemiological studies suggest a bidirectional association between depression and obesity; however, the biological mechanisms that link the development of depression to a metabolic disorder remain unclear. Even though nuclear receptor peroxisome proliferator-activated receptor γ (PPARγ) agonists show anti-depressive effect, and high-fat diet-(HFD)-induced PPARγ dysfunction is involved in the pathogenesis of metabolic disorders, the neuronal PPARγ has never been studied in HFD-induced depression. Thus, we aimed to investigate the effect of neuronal PPARγ on depressive-like behaviors in HFD-induced obese mice.We fed male C57BL/6 J mice with HFD to generate obese mice and conducted a series of behavioral tests to assess the effects of HFD feeding on depression. We generated neuron-specific PPARγ knockout mice (NKO) to determine whether neuronal PPARγ deficiency was correlated with depressive-like behaviors. To further prove whether PPARγ in the medial prefrontal cortex (mPFC) neurons is involved in depressive-like behaviors, we applied AAV- CaMKIIα-Cre approach to specifically knockout PPARγ in the mPFC neurons of LoxP mice and used AAV-syn-PPARγ vectors to overexpress PPARγ in the mPFC neurons of NKO mice.We observed a low mPFC PPARγ level and an increase in depressive-like behaviors in the HFD-fed mice. Moreover, neuronal-specific PPARγ deficiency in mice induced depressive-like behaviors, which could be abolished by imipramine. Furthermore, overexpressing PPARγ in the mPFC reversed the depressive-like behaviors in HFD-fed mice as well as in neuronal-specific PPARγ knockout mice.These results implicate that dysregulation of neuronal PPARγ in the mPFC may contribute to an increased risk for depression in obese populations.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Depression; High-fat diet; Medial prefrontal cortex; Obesity; PPARγ; Rosiglitazone

Mesh:

Substances:

Year:  2022        PMID: 35467259     DOI: 10.1007/s12035-022-02806-6

Source DB:  PubMed          Journal:  Mol Neurobiol        ISSN: 0893-7648            Impact factor:   5.590


  32 in total

Review 1.  Peroxisome proliferator-activated receptor gamma and metabolic disease.

Authors:  T M Willson; M H Lambert; S A Kliewer
Journal:  Annu Rev Biochem       Date:  2001       Impact factor: 23.643

Review 2.  New approaches to antidepressant drug discovery: beyond monoamines.

Authors:  Olivier Berton; Eric J Nestler
Journal:  Nat Rev Neurosci       Date:  2006-02       Impact factor: 34.870

Review 3.  Overweight, obesity, and depression: a systematic review and meta-analysis of longitudinal studies.

Authors:  Floriana S Luppino; Leonore M de Wit; Paul F Bouvy; Theo Stijnen; Pim Cuijpers; Brenda W J H Penninx; Frans G Zitman
Journal:  Arch Gen Psychiatry       Date:  2010-03

4.  Anti-diabetic drugs inhibit obesity-linked phosphorylation of PPARgamma by Cdk5.

Authors:  Jang Hyun Choi; Alexander S Banks; Jennifer L Estall; Shingo Kajimura; Pontus Boström; Dina Laznik; Jorge L Ruas; Michael J Chalmers; Theodore M Kamenecka; Matthias Blüher; Patrick R Griffin; Bruce M Spiegelman
Journal:  Nature       Date:  2010-07-22       Impact factor: 49.962

5.  Pro12Ala polymorphism in PPARgamma2 associated with depression in Chinese nonagenarians/centenarians.

Authors:  Yue Ji-Rong; Dong Bi-Rong; Huang Chang-Quan; Lu Zhen-Chan; Wu Hong-Mei; Zhang Yan-Ling; Tod A Mattis
Journal:  Arch Med Res       Date:  2009-07-26       Impact factor: 2.235

Review 6.  The molecular neurobiology of depression.

Authors:  Vaishnav Krishnan; Eric J Nestler
Journal:  Nature       Date:  2008-10-16       Impact factor: 49.962

7.  Depressive symptoms and metabolic syndrome: is inflammation the underlying link?

Authors:  Lucile Capuron; Shaoyong Su; Andrew H Miller; J Douglas Bremner; Jack Goldberg; Gerald J Vogt; Carisa Maisano; Linda Jones; Nancy V Murrah; Viola Vaccarino
Journal:  Biol Psychiatry       Date:  2008-07-02       Impact factor: 13.382

8.  Antidepressant-like effects of rosiglitazone, a PPARγ agonist, in the rat forced swim and mouse tail suspension tests.

Authors:  Amany Ali Eissa Ahmed; Nawal Mohammed Al-Rasheed; Nouf Mohammed Al-Rasheed
Journal:  Behav Pharmacol       Date:  2009-10       Impact factor: 2.293

Review 9.  Metabolic disturbances connecting obesity and depression.

Authors:  Cecile Hryhorczuk; Sandeep Sharma; Stephanie E Fulton
Journal:  Front Neurosci       Date:  2013-10-07       Impact factor: 4.677

10.  Role of the adipose PPARγ-adiponectin axis in susceptibility to stress and depression/anxiety-related behaviors.

Authors:  M Guo; C Li; Y Lei; S Xu; D Zhao; X-Y Lu
Journal:  Mol Psychiatry       Date:  2016-12-13       Impact factor: 15.992

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.